About Momentum Bioscience
Momentum Bioscience is a company based in Cardiff (United Kingdom) founded in 2008. Momentum Bioscience has raised $5.75 million across 2 funding rounds from investors including IIG PLC. The company has 12 employees as of October 31, 2021. Momentum Bioscience offers products and services including SepsiSTAT System and Rapid Phenotypic AST. Momentum Bioscience operates in a competitive market with competitors including Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter Cardiff, United Kingdom
- Employees 12 as on 31 Oct, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Momentum Bioscience Limited
- Date of Incorporation 17 Oct, 2005
- Jurisdiction CARDIFF, WALES
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.75 M (USD)
in 2 rounds
-
Latest Funding Round
$5.4 M (USD), Series A
Sep 15, 2021
- Investors
-
Employee Count
12
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Momentum Bioscience
Momentum Bioscience offers a comprehensive portfolio of products and services, including SepsiSTAT System and Rapid Phenotypic AST.
Enables rapid detection and testing of bloodstream infections from blood samples.
Accelerates antibiotic susceptibility results for sepsis treatment.
People of Momentum Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Momentum Bioscience
Momentum Bioscience has successfully raised a total of $5.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.4 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Momentum Bioscience
Momentum Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IIG PLC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by IIG toward life sciences startups.
|
Locked | Locked | Locked |
Investor details for Momentum Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Momentum Bioscience
Investment portfolio details for Momentum Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Momentum Bioscience
Detailed financials for Momentum Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Momentum Bioscience Comparisons
Peer comparison for Momentum Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Momentum Bioscience
Momentum Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
Detailed competitors of Momentum Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Momentum Bioscience
Complete news archive for Momentum Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Momentum Bioscience
Momentum Bioscience was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Momentum Bioscience is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Momentum Bioscience is a funded company, having raised a total of $5.75M across 2 funding rounds to date.
As of Oct 31, 2021, the latest employee count at Momentum Bioscience is 12.
Developer of diagnostic solutions for the detection of infectious diseases. Its proprietary platform Enzymatic Template Generation Amplification (ETGA) detects microbial infections by measuring nucleic acid modifying enzymes. The companys flagship product is Cognition is based on ETGA technology.
Momentum Bioscience's top competitors include Visby Medical, Inflammatix and MeMed.
Momentum Bioscience offers SepsiSTAT System and Rapid Phenotypic AST.
Momentum Bioscience has 1 investor. Key investors include IIG PLC.